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Genetics in Psychosomatic Medicine: Research Designs
and Statistical Approaches
JEANNE M. MCCAFFERY, PHD, HAROLD SNIEDER, PHD, YANBIN DONG, MD, PHD, AND ECO DE GEUS, PHD
It has become increasingly clear that genetic factors influence many of the behaviors and disease endpoints of interest to
psychosomatic medicine researchers. There has been increasing interest in incorporating genetic variation markers into psycho-
somatic research. In this Statistical Corner article, we build on the valuable experiences gained during two workshops for “starters
in the field” at the American Psychosomatic Society and the Society for Psychophysiological Research to review two common
genetically informative research designs for human studies: twin and genetic association studies. We outline statistical techniques
for each and, for genetic association studies, address special topics, including the treatment of race and ethnicity, gene  gene and
gene environment interaction, haplotype analysis, and power and sample size. Finally, we discuss the issue of nonreplication and
interpretation of results derived from genetic association studies. We hope this overview of twin and genetic association designs
will support and stimulate thoughtful applications of genetic approaches within psychosomatic medicine. Key words: statistics,
genetics, twin studies.
MZ  monozygotic; DZ  dizygotic; SES  socioeconomic status;
SEM  structural equation modeling; SBP  systolic blood pres-
sure; HWE  Hardy-Weinberg equilibrium; SNP  single nucleo-
tide polymorphism; VNTR  varying number of tandem repeats;
LD linkage disequilibrium; TDT transmission disequilibrium test.
INTRODUCTION
Recently researchers in psychosomatic medicine have wit-nessed an increasing awareness of the importance of ge-
netic factors in stress and health relationships (1–6). Twin and
family studies have confirmed a clear-cut genetic contribution
to cardiovascular disease (7–11) and its major risk factors
(12–21). In addition, tracking of these risk factors over time
(22–25) as well as their tendency to cluster, as in the metabolic
syndrome (26–29), is largely due to genetic factors. This
finding is relevant to psychosomatic medicine. By lumping
together subjects who are genetically susceptible to the effects
of psychosocial stressors with those subjects who are not
susceptible, previous studies may have underestimated the
significance of negative health effects in the former suscepti-
ble group. Future research, therefore, should strive to include
genetic variation as a potential source of individual variance in
psychosomatic risk factors.
We aim to review two common research designs in genet-
ics. The starting point of genetic research on any risk factor is
the establishment of significant heritability. The twin study has
been the work horse of such heritability estimation and we will
start by reviewing its principles. Because most researchers in this
field are expected to use candidate gene association approaches,
the largest part of this paper will consider the statistical methods
for this type of association. Throughout, we based this paper on
the valuable experiences gained during two workshops for “start-
ers in the field” at the American Psychosomatic Society (30) and
the Society for Psychophysiological Research (31). Although we
expect that some statistical approaches may be familiar to the
readers of Psychosomatic Medicine, some genetic terminology
may not be. A glossary of genetic terms is available at http://
www.genome.gov/glossary.cfm.
Twin Studies
Perhaps one of the most robust clinical observations in psy-
chiatry and cardiology is that disease tends to “run in the family”.
However, familial resemblance for a trait cannot automatically be
attributed to genes. In family studies, the genetic relatedness is
confounded with the shared environment of the family mem-
bers. This includes potentially important sources of interindi-
vidual variance like culture, socioeconomic status (SES),
neighborhood, school, sports club, peers, family diet, and
parental rearing style and attitudes. A unique experiment of
nature has provided the solution to separating genetic and
shared environmental influences: the existence of monozy-
gotic (MZ) and dizygotic (DZ) twins.
Because MZ twins reared together share part of their en-
vironment and 100% of their genes (32) except for some rare
exceptions, any resemblance between them is attributed to
these two sources of covariance. The extent to which MZ
twins do not resemble each other is ascribed to so-called
unique or nonshared environmental factors like differential
jobs or lifestyle, accidents or other life events, and in child-
hood, differential treatment by the parents, and nonshared
peers. Unique environment also includes measurement error.
Resemblance between DZ twins reared together is ascribed to
the sharing of both environment and genes. DZ twins share on
average 50% of their segregating genes; any resemblance
between them attributable to genetic influences will be less
than for MZ pairs. The extent to which DZ twins do not
resemble each other is due to unique environmental factors
and nonshared genetic influences.
Based on molecular genetic theory, we can further divide
the genetic variance in two separate parts: a) additive and b)
dominant genetic variance. Genetic effects at a single locus
are called additive when the effect of one parental allele is
added to the effect of the other parental allele. Genetic effects
are called dominant when they deviate from purely additive
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effects, e.g., when the two alleles of the locus interact. The
total additive and dominance variance estimated in twin stud-
ies reflects the additive and dominant effects summed over all
contributing loci. The total variance in any trait can arise from
the four components identified above: a) unique environmen-
tal factors (“E”), b) shared or common environmental factors
(“C”), c) additive (“A”) genetic factors, and d) dominant
(“D”) genetic factors. For simplicity, we will first consider the
case where there is no interaction or correlation among these
four components. The value of a trait is then defined as P 
A  D  C  E, where P is a quantitative trait; A and D are
the effects of additive and dominant genetic factors; and C and
E are the effects of common and unique environmental factors
(with E also including the residual variance due to measure-
ment error). The variance (V) in trait P then becomes VP 
VA  VD  VC  VE, and the MZ and DZ twin covariances
become Cov(MZ)  VA  VD  VC, and Cov(DZ) 
0.50VA  0.25VD  VC, respectively (33,34).
From the pattern of MZ and DZ twin correlations, we can
obtain a first crude estimate of these variance components.
However, we cannot estimate common environmental influ-
ences and dominant genetic influences at the same time.
Therefore, we first test for evidence of dominance, which
would yield MZ correlations that are much larger than twice
the DZ correlation (e.g., rMZ  0.42, rDZ  0.10). If there is
no evidence for dominance, the contribution of additive ge-
netic influences to the total variance in a trait can be estimated
as twice the difference between the MZ and DZ correlations
(VA/VP  2(rMZ  rDZ)). For instance, typical MZ and DZ
correlations for resting systolic blood pressure (SBP) are 0.52
and 0.26 (17); therefore, the percentage of SBP variance
explained by the additive genetic influences is estimated at
52%. An estimate of the proportional contribution of the
shared environmental influences to the total phenotypic vari-
ance is given by subtracting the MZ correlation from twice the
DZ correlation (VC/VP  2rDZ  rMZ). The proportional
contribution of the unique environmental influences can be
obtained by subtracting the MZ correlation from unit correla-
tion (VE/VP  1  rMZ). If, for instance, the MZ correlation
for exercise behavior of adolescents is 0.8 and the DZ corre-
lation is 0.6, estimates of the relative contribution VA, VC, and
VE to total variance are 40%, 40%, and 20%, respectively
(35). If there is evidence for genetic dominance (i.e., the MZ
correlation is larger than twice the DZ correlation), the estimate
for the proportional contribution of additive genetic influences
changes to VA/VP  (4rDZ rMZ). An estimate of the propor-
tional contribution of the dominant genetic influences is then
obtained by subtracting four times the DZ correlation from twice
the MZ correlation (VD/VP  2rMZ  4rDZ).
These are rules of thumb only. They are based on a model
that has no interaction terms (e.g., A  E  0) and assumes
that mating is random, and that the genetic and environmental
factors are uncorrelated in the population (e.g., Cov(A, C)  0).
If these assumptions do not hold, these intuitively simple rules
may yield incorrect estimates. Interaction across multiple loci
(gene-gene interaction or epistasis), for instance, will reduce
the DZ correlation and inflate the estimate of genetic domi-
nance. Interaction of genetic and unique environmental influ-
ences will inflate the contribution of the unique environment
and underestimate genetic influences, whereas interaction of
genetic and shared environmental factors will inflate the con-
tribution of genetic influences (36,37). Incorrect estimates
may also arise when genetic and environmental factors are
correlated, for instance, because people actively seek environ-
ments that fit their temperament and skills, or because parents
pass on their genes as well as a specific environment to their
offspring (vertical cultural transmission). Finally, phenotypic
assortment, which is nonrandom mate selection based on
shared traits (e.g., education, religion, lifestyle choices), in-
creases both MZ and DZ twin correlations that lead to an
inflated estimate of the contribution of shared environment.
The other major assumption of the classical twin study is
the “Equal Environments Assumption” that MZ twin pairs
experience the same degree of environmental similarity as DZ
twin pairs. If this is not the case and MZ twin pairs are
exposed to more similar environments than DZ pairs, then any
excess similarity between MZ pairs compared with DZ pairs
may result from environmental rather than genetic factors.
Several empirical findings argue in favor of the validity of the
equal environment assumption (38,39). For instance, herita-
bility estimates obtained from twin-adoption studies (where
the MZ twins are raised in entirely different families) closely
resemble those from ordinary twin studies. Also, studies of
parents with misclassified twins (the parents always thought
the twin was MZ but they turned out to be DZ and vice versa)
have not shown any consistent effect of perceived zygosity on
twin similarity for a range of personality traits.
Structural equation modeling (SEM) of twin variance-co-
variance data has several advantages over merely comparing
the MZ and DZ correlations (34,40,41). SEM allows the
comparison of the fit of alternative models (e.g., ACE versus
AE) with the observed data and provides confidence intervals
around the estimates for VA, VC/VD, and VE. In SEM, the
relationship between several latent unobserved and observed
variables is summarized by a series of structural equations. In
a genetic analysis, these equations relate the observed trait to
latent genetic and environmental variables (i.e., the additive
and dominant effects of genes and common and unique envi-
ronmental influences). From these equations, it is possible to
derive the variance-covariance matrix implied by the model
through covariance algebra (42). The variances and covari-
ances for the basic twin model can be represented by linear
structural equations of the total phenotypic variance (VP) of
both MZ and DZ twins (VP VA VD VC VE), the MZ
covariance (Cov[MZ]  VA  VD  VC), and the DZ
covariance (Cov[DZ]  0.50VA  0.25VD  VC). As stated
earlier, since we have four unknowns and only three observa-
tions, at most only one of VC and VD can be estimated. This
is not to say that VC and VD cannot both contribute to the
phenotypic variance of a trait but rather they cannot be esti-
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mated simultaneously with data from twins alone. Conse-
quently, when the correlation between MZ twins is less than
twice the DZ correlation, we estimate VC and assume that
genetic dominance is absent; conversely, when the MZ cor-
relation is more than twice the DZ correlation, we estimate VD
and assume that VC is zero.
Structural equation models may be represented diagrammat-
ically using path diagrams, which can be helpful in understanding
complex multivariate designs. A first simple univariate example
relevant to psychosomatic medicine is depicted in Figure 1.
SBP is measured at rest in MZ and DZ twin pairs. Our model
specifies one latent genetic factor, one latent shared environ-
mental factor, and one latent unique environmental factor, all
with a variance of 1. In the example, dominance is assumed
not to influence SBP and all the genetic variance is assumed
to be additive; this seems to be the case in reality as well (17).
Path coefficients “a,” “c,” and “e” represent the factor load-
ings of SBP on the latent factors. As seen from biometrical
theory, a2  VA, c
2  VC, and e
2  VE (43). In structural
equation modeling, parameter estimates for these path coeffi-
cients are obtained by using a fitting function, which quanti-
fies the difference between the observed variance-covariance
matrix and the variance-covariance matrix implied by the
model. These functions provide a measure of how likely the
data are under the specified model for the causes of familial
resemblance. They also provide the significance of each of the
model parameters (e.g., a2, c2, and e2). The relative contribu-
tion of the genetic factor to the total variance in resting SBP,
also known as the heritability (h2), now obtains as the ratio of
a2/(a2  e2  c2).
One huge advantage of structural equation modeling is that
it can easily be expanded to the multivariate case, enabling us
to examine if two traits are correlated through common ge-
netic or through common environmental effects. A typical
example in our field would be to detect the nature of the
well-known tracking of SBP level across time, which in adult-
hood is about 0.55 over 5- to 10-year periods. This tracking
may reflect the effects of an underlying genetic factor affect-
ing SBP across time points, but it may also reflect the effects
of chronic stress or other persistent unique environmental
factor. Figure 2 depicts a bivariate twin model that can test this
and various other hypotheses. In the example, we assume that
only two sources of variance explain individual differences in
SBP at the two time points: additive genetic and unique
environmental factors; again this seems to be true in reality
(23,44). If coefficient a22 can be set to zero without a signif-
icant loss of fit, only a single genetic factor influences SBP at
both time points; i.e., there is no additional contribution of
genetic factors at time 2 that is not already seen at time 1. If
coefficient e21 can be set to zero, then the unique environ-
mental factors causing variance in SBP at time points 1 and 2
are uncorrelated. If coefficient a21 is significant and e21 is not,
this means that the tracking of SBP over time is caused
entirely by underlying genetic factors. Such a structure was
found across multiple time points in Dutch twin samples (23)
whereas in Australian and American twins both genetic and
environmental factors contributed to temporal stability of SBP
(44,45).
Multivariate structural equation models of twin data can
also be used to analyze the interaction between siblings, the
genetic and environmental correlation between different traits,
and the direction of causation between variables (34,43,46). It
is also easy to extend the classical twin design by including
other informative relationships in the analysis including sib-
lings (47,48), parents of twins (25,49,50), the offspring of MZ
and DZ twins (51,52), and the spouses of twins (53–55). These
designs can quantify the effects of phenotypic assortment and
vertical cultural transmission, which the classical twin study
cannot do. Finally, if important aspects of the environment are
Figure 1. Variance decomposition in twin studies using a path model.
Following standard path tracing rules, the expectation for the variance and
covariances obtains as: Variance (SBP)  (a*1*a)  (c*1*c)  (e*1*e) 
a2  c2  e2; monozygotic covariance (SBP)  (a*1*a)  (c*1*c)  a2 
c2; dizygotic covariance (SBP)  (a*0.5*a)  (c*1*c)  0.5a2  c2. Path
coefficients a, c, e can be estimated by a maximum likelihood estimation
procedure that optimally fits the expected variance and covariances to the
observed variance in SBP and the observed cross-twin SBP covariances in
MZ and DZ twin pairs. SBP  systolic blood pressure.
Figure 2. Bivariate twin model of the tracking of systolic blood pressure
(SBP) across time. From the bivariate path diagram, we can compute the
genetic correlation between the two time points (rg) as the genetic covariance
divided by the square root of the genetic variances of both traits (a11*a21/
(a11
2*(a21
2  a22
2)). The unique environmental correlation obtains as
e11*e21/(e11
2*(e21
2  e22
2)).
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measured, the presence and extent of gene  environment
interaction can be tested (36,37).
An example of a twin model incorporating gene-environ-
ment interaction is given in Figure 3, where we additionally
control for possible gene-environment correlation. Regular
exercise is known to be associated with lowered SBP (56).
However, the extent of SBP reduction after an identical exer-
cise program shows large differences between individuals;
family studies (98,99) have suggested these differences to be
partly heritable (57). This suggests that subjects with different
genetic make-up can differ in their sensitivity to the beneficial
effects of exercise. To account for this gene-exercise interac-
tion, the path loadings on SBP in Figure 3 are weighted for the
exercise status (which is “yes”  1/“no”  0) of the twins. If
a model with nonzero  weights for the genetic factors fits the
observed data better than a model with zero  weights for the
genetic factors, we have formal evidence of gene-exercise
interaction. Some complexity is introduced to the model by
allowing part of the association between exercise behavior and
blood pressure to derive from genes that independently influ-
ence both traits (i.e., the latent genetic factor Ac). This phe-
nomenon is known as “pleiotropy” and may play a role in
many traits that can be considered “environmental” modifiers
of risk factors, on the one hand (e.g., lifestyle, SES, chronic
stress), but may themselves be heritable. When there is evi-
dence of potential gene-environment correlation, i.e., when
the “environmental factor” itself shows heritability, as is the
case for exercise behavior (35), allowing for gene-environ-
ment correlation as in Figure 3 is prudent.
In short, twin studies provide a first necessary step in
genetic research by establishing that genes contribute to the
observed population variation in psychosomatic risk factors
and by estimating the size of this genetic contribution relative
to other factors that create resemblance within families. Twin
studies do not identify the actual genes. This effort requires
molecular genetic research on the actual genetic variation.
Molecular Genetics
That DZ twins share, on average, 50% of their genetic
material refers exclusively to the part of the genes in which
people can differ. Any one person’s deoxyribonucleic acid
(DNA) is 99.9% the same as any other person’s DNA. The
0.01% difference in the sequence of DNA among individuals
is the source of all genetic variation. Variation in a single gene
is responsible for some disorders, such as cystic fibrosis and
sickle cell disease. Variation in multiple genes, environmental
factors, gene by gene interactions, and gene by environment
interactions are thought to account for complex traits, includ-
ing most traits of interest in psychosomatic medicine.
A gene consists of two units of information, the alleles.
One allele is inherited from the father and one from the
mother. Together they constitute the genotype, which may be
homozygous (same allele from both parents) or heterozygous
(different allele from each of the parents). Under a simple
Mendelian inheritance model and random mating assumption,
lack of selection according to genotype, and absence of mu-
tation or migration, the frequencies of the genotypes in the
population are perfectly predicted by the frequencies of the
two alleles, which is referred to as Hardy-Weinberg equilib-
rium (HWE) (58). As an example, consider a gene with two
alleles, denoted “short” (s) with frequency p and “long” (l)
with frequency q. Let the least frequent, or minor, allele s take
up 40% of all alleles in the population (p  .4). The three
potential genotypes, ss, ls and ll, have expected frequencies,
namely, p2 (.16), 2pq (0.48), and q2 (0.36). A 2 test for HWE
compares these expected genotype frequencies with the ob-
served genotype frequencies; a significant 2 test indicates
that HWE does not hold. Many of the association analyses
discussed below require HWE to hold.
Large-scale genetic variation includes loss or gain of chro-
mosomes or breakage and rejoining of chromatids. This vari-
ation is abnormal and often leads to profound developmental
problems. Smaller-scale genetic variation is at the level of a
single allele and contributes to most of the normal variation in
the population. Smaller-scale genetic variation can be classi-
fied into three groups: a) single nucleotide polymorphisms
(SNPs), b) insertion/deletion polymorphisms, and c) varying
number of tandem repeats (VNTR). Deletion occurs when one
or more nucleotides are eliminated from a sequence, whereas
insertion occurs when one or more nucleotides are inserted
into the sequence. VNTRs (which include very short repeats
or microsatellites) are short identical segments of DNA
aligned head to tail in a repeating fashion. The number of
repeated segments at a locus varies between individuals. An
SNP is defined as a single base substitution. SNPs are the most
abundant form of DNA variation in the human genome with
approximately 7 million common SNPs with a minor allele
frequency of at least 5% across the entire human population
(59–62).
Figure 3. Twin model testing gene-environment interaction in the presence
of gene-environment correlation. Ac is a hypothetical set of pleiotropic genes
that lower SBP and increase the drive to exercise regularly. As are genes
specific to SBP. Regular exercise is simultaneously allowed to act as an
environmental modulator of the genetic effects on SBP (1, 2) as well as of
the unique environmental effects on SBP (3, 4). Significance of the gene-
exercise interactions can be tested by comparing this full model to models
with 1 or 2 set to zero. SBP  systolic blood pressure.
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Candidate Gene Association Studies
Candidate gene association studies test if a particular allele
in a candidate gene and a trait co-occur above chance level,
given the frequency of the allele and the distribution of the
trait in the population (63). In these studies, selection of
candidate genes a priori is required. The selection of genes
may be based on the biological role of the gene in a causative
pathway (physiological candidate) or a location close to a
peak from a linkage, or genetic mapping, study (positional
candidate). Ideally, the gene fits both criteria. In a direct
association study, one or more putatively functional variants
are genotyped and serve as the independent variable predict-
ing a dependent variable, the trait of interest. It is presumed
that the selected variant is causative in the trait of interest
although, in practice, association may be attributable to link-
age disequilibrium (LD) with another functional site nearby.
Genetic variants should be prioritized by apparent functional
significance or location within coding, promoter, or splice
regions. These typically include SNPs, VNTRs, and insertion/
deletion polymorphisms.
An example of a direct association study is examining the
role of variants within - and -adrenergic receptor genes as
predictors of blood pressure level. The adrenergic receptor
genes are good biological candidates due to their location on
the heart (1), in the vasculature (1, 2), or within the central
nervous system (2a), and their involvement in cardiovascular
regulation. In addition, individual variants within the genes
have been shown to be functional. For example, receptors with
the C 3 G SNP at base pair (bp) 1165 within ADRB1
(1-adrenoreceptor gene), resulting in an amino acid substi-
tution from arginine to glycine at position 389, show increased
adenylyl cyclase activity in the presence of an agonist. In a
study of young adult twins, the genotypes at this SNP were
examined in relation to blood pressure at rest and in response
to a combined mental arithmetic and Stroop task (3). After
statistically controlling for age, sex, and body mass index,
participants carrying any G allele at base pair (bp) 1165 in
ADRB1 exhibited increased resting SBP (GG/GC 115.52
8.47 versus CC  112.94  10.14 mm Hg), DBP (GG/GC 
61.88 6.32 versus CC 59.64 7.16 mm Hg), and a larger
DBP response (GG/GC  6.97  6.94 versus CC  4.85 
6.87 mm Hg) to mental challenge as compared with CC
genotypes (CG and GG groups were combined due to the
small sample size for GG homozygotes).
There are numerous online resources with information about
candidate genes and variation in or near the genes of interest. The
National Center for Biotechnology Information home page,
available at http://www.ncbi.nlm.nih.gov/, includes resources
such as Online Medelian Inheritance in Man (OMIM), dbSNP,
the Genome Database and Pubmed. Other excellent resources
include Ensembl available at http://www.ensembl.org/, the Ge-
nome Browser from the University of California, Santa Cruz
available at http://genome.ucsc.edu/, the International Hapmap
project available at http://www.hapmap.org/, the SNP Consor-
tium (TSC) available at http://snp.cshl.org/, the SeattleSNPs vari-
ation discovery resource available at http://pga.gs.washington.
edu/, and SNPper, a Web-based application to automate the tasks
of extracting SNPs from public databases available at http://
SNPper.chip.org/.
The statistical approach to association studies depends on
the research design (63). Common research designs for asso-
ciation studies include cohort designs and case-control de-
signs. Within these designs, special topics with statistical
implications include treatment of race and ethnicity, gene 
gene and gene  environment interaction, and use of haplo-
types and power.
Cohort Studies: Quantitative Traits
Single diallelic polymorphisms, such as SNPs, may be
analyzed using general linear modeling. For individual SNPs,
genotype (e.g., GG, CG, CC for a G to C substitution) typi-
cally serves as the independent variable. In the absence of
knowledge about whether alleles at a given site function in an
additive, dominant, or recessive manner (as is the case for
many of the polymorphisms of interest in psychosomatic
medicine), the three possible genotypes should be treated as
independent groups. This would translate to a between-sub-
jects group factor with the number of levels (k) equal to the
number of genotypes and k-1 degrees of freedom (df) (i.e., 2
df). Evidence for apparent dominance of one allele over an-
other may be detected through posthoc group contrasts (e.g.,
GG  CG  CC). Covariates and additional predictors of the
dependent variable may also be incorporated.
Within a regression framework, the most general model for
genetic effects at a single locus includes a term for linear
effects of a given allele and an additional parameter for the
deviation from this linear effect, i.e., a dominance term (63).
For the linear term, genotypes (e.g., GG, CG, and CC) are
assumed to function in an additive manner and are coded as 0,
1, and 2, reflecting dose of the C allele. The associated 
weight is the additive effect of the C allele. This linear model
alone predicts that the mean of the heterozygotes (CG) will be
located at the midpoint between the two types of homozygotes
(GG, CC); however, in practice, this may or may not be the
case. Deviation of the mean of the heterozygotes from the
midpoint between the means of the homozygotes suggests that
one allele is dominant over the other. To quantify this effect, an
additional, dominance term, is necessary. Specifically, genotypes
GG, CG and CC may be coded 0, 1, and 0 with the associated 
weight reflecting deviation of the heterozygotes from the mid-
point of the two homozygous groups, as would be predicted by
the linear term alone. The general regression framework for a
diallelic locus is given by P  aA dD e, where P is
a quantitative trait;  is the baseline mean of P; A and D are
dummy variables reflecting coding for linear and nonlinear ef-
fects of the underlying genotype at a single locus; and e is a
residual error term assumed to be normally distributed.
For polymorphisms with more than two alleles (e.g., mic-
rosatellites), genotypes may be treated individually, although
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there will be little power to examine the effects of the more
rare alleles. Alternatively, alleles may be ranked according to
function based on in vitro assays (64). If there are no func-
tional data available and several rare genotypes, it may be
necessarily to limit analyses to the most common genotypes to
preserve statistical power.
Case-Control Studies: Disease Traits
Case-control genetic association studies are typically com-
prised of a group of cases with a trait of interest and well-matched
controls. Ideally, the cases and controls should represent “iden-
tical” subsamples from a single population differing only on
the trait of interest (65). Statistical analyses compare allele
frequencies or genotypes across cases and controls. In well-
matched samples, differences in genotypes across cases and
controls may be tested using 2 tests. Alternatively, the risk of
having the disorder may be modeled using logistic regression
with a 2 df test. Within this approach, the log odds of express-
ing the disease trait is modeled as a function of the additive
effects of the dose of one of the alleles (e.g., 0, 1, or 2 copies
of the C allele for genotypes GG, CG, and CC, respectively)
and a dominance term representing deviance from this addi-
tive pattern (e.g., genotypes GG, CG, and CC coded as 0, 1,
and 0). For the additive term, the log odds of disease expres-
sion for heterozygotes is midway between the log odds of the
two homozygous groups. The dominance term quantifies the extent
to which the log odds for heterozygotes differs from the additive
prediction. The general logistic regression framework for a diallelic
locus is given by ln(P/1  P)    aA  dD  e, where
P is the binary expression of a phenotype;  is the baseline log
odds of P; A and D are dummy variables reflecting coding for
linear and nonlinear effects of the underlying genotype at a
single locus; and e is a residual error term assumed to be
normally distributed. The natural log raised to the power of the
additive  weight (ea or Exp (a)) reflects the change in odds
of expression of the phenotype based on a unit increase in
allele dose. The GG genotype becomes the reference group (0
allele) and the effect of genotype is quantified by determining
if there is a significant change in the probability of the ex-
pression of the phenotype for each additional C allele (CG 
1 additional allele and CC genotypes  2 additional alleles).
The natural log raised to the power of the dominance  weight
reflects the deviation of heterozygotes from the midpoint of
the log odds for the two homozygous groups. For a binary
genotype (i.e., GG versus CG or CC), natural log raised to the
power of the additive  weight would be an odds ratio.
Treatment of Race and Ethnicity
In cohort-based and case-control analysis of unrelated indi-
viduals, spurious genetic association may result due to differ-
ences in allele frequencies and the trait of interest in subgroups
within the larger population, often reflecting racial or ethnic
groups (population stratification). The classic example of pop-
ulation stratification is a hypothetical association between
chopstick use and any genetic marker that differs markedly
between Asian and Caucasian populations in a larger popula-
tion with substantial representation of both ethnicities, such as
San Francisco, California (66). It has been argued that there
have been relatively few documented instances of bias due to
population stratification reported in the literature and that
population-based studies are largely robust to this type of bias
(67). However, recent empirical tests do find evidence of
stratification effects, particularly among populations that have
recently been mixed from two or more distinct parental pop-
ulations (genetic admixture), including African Americans
and Hispanic Americans (68).
Population stratification is essentially a problem of sample
matching, occurring primarily when the genetic background of
the cases differs from that of controls (67). Accordingly, it is
possible that matching cases and controls on self-reported race
in homogeneous populations (such as European Americans)
will mitigate concerns about population stratification. Two
methods are available to control for stratification using mark-
ers throughout the genome. In structure assessment (69–74),
genetic markers, either anonymous markers or markers that
differ substantially among ethnic groups, are used to predict
membership in homogeneous subgroups within a stratified
population. Once identified, genetic associations may be con-
ducted within these subgroups to ensure a similar genetic
background of cases and controls. A second method, genomic
control (75–79), uses anonymous genetic markers to estimate
the degree of inflation of the 2 statistic due to population
stratification and yields a correction factor to account for these
background genetic effects in genetic association studies.
With the rapid reduction in genotyping costs and further
development of these methods (69), it is likely that the threat
of population stratification will be routinely controlled in
cohort and case-control genetic association studies using these
types of techniques.
Another good method to ensure genetic matching is to
conduct genetic studies within families. Tests using within-
family controls to control for population stratification are collec-
tively known as transmission disequilibrium tests (TDTs). The
classic TDT requires information on trios, i.e., parents and an
affected offspring. The principal idea is that the allele associ-
ated with disease will be transmitted more often to an affected
offspring (80). The TDT compares the actual and expected
probabilities of transmission of the allele (an offspring has an
expected chance of 0.5 of receiving a specific allele from
either the mother or the father). Overtransmission can only
occur if the marker and disease locus are linked. However,
power of the TDT is less than for an association test based on
cases and controls because only heterozygote parents provide
information about preferential allele transmission. After the
introduction of the classic TDT by Spielman and colleagues
(80), the TDT has undergone many developments and has, for
example, been adapted for quantitative traits and nuclear families
of any size (81–83) as well as for haplotypes (84).
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Gene  Gene and Gene  Environment Interaction
From a genetics perspective, nearly all psychosomatic traits
are considered “complex,” meaning that the causal pathways
are likely to involve multiple genes of small effect, environ-
mental factors, and gene  gene and gene  environment
interaction (85). Genetic interaction within a given locus is
termed genetic dominance. Interaction between two loci is
termed epistasis. However, a distinction between epistasis refer-
ring to a statistical interaction and that referring to a physical
interaction of gene products is warranted, as the presence of
statistical interaction does not necessarily imply an underlying
biological interaction (86,87). Similarly, statistical gene- en-
vironment interactions should be interpreted with caution as
the mathematical model may again have no obvious biological
interpretation (88).
Modeling statistical gene  gene or gene  environment
interaction may be accomplished by incorporating two genetic
predictors or one genetic and one environmental predictor into
linear or logistic regression in standard statistical packages
and testing for their interaction (87,89). The choice of scale
becomes important because factors that are additive with
respect to an outcome in one scale may exhibit interaction if
a transformed scale is used. For linear regression with two
genetic predictors, the general regression model is given by:
P  a1A1d1D1a2A2d2D2
a1a2A1A2a1d2A1D2a2d1A2D1d1d2D1D2e
where P is a quantitative trait;  is the baseline mean of P; A1,
A2, D1, and D2 are dummy variables coding for the additive
and dominance effects of the underlying genotype for sites 1
and 2; and e is a residual error term assumed to be normally
distributed. Statistical epistasis implies that at least one of the
interaction coefficients differs significantly from zero.
For gene  environment interaction, at least one genetic
and one environmental predictor are included in the regression
equation plus the interaction of the additive and dominance
term with the environmental predictor. Statistical interaction
implies that either of the interaction terms differs significantly
from zero. The general regression framework for a gene 
environment interaction for a continuous trait is given by:
P  aAdDeEaeAEdeDEe
where P is a quantitative trait;  is the baseline mean of P; A
and D are dummy variables coding for linear and nonlinear
effects of the underlying genotype; E is a measured environ-
mental factor; and e is a residual error term assumed to be
normally distributed. Assuming no genetic dominance or as-
sociated interactions, this equation reduces to:
P  aAeEaeAEe
Finally, if the genotype is correlated to the environmental
risk factor (e.g., genetic susceptibility to aggression and pa-
rental maltreatment), the interpretation of the statistical inter-
action is not straightforward (90). In addition, observational
studies can be associated with substantially less power than
well-designed experiments to detect interaction effects (91),
suggesting that controlled interventions may be a useful alter-
native to observational studies in detecting gene  environ-
ment interaction effects. An example would be to test whether
certain candidate genes in the sympathetic nervous system
(e.g., ADRB2, or the 2-adrenoreceptor gene) may explain
part of the large individual variability in the beneficial effects
of exercise on blood pressure.
Haplotype Analysis
The primary disadvantage of characterizing a single variant
per gene is that there may be additional variants within the
gene that are relevant to the trait of interest but are not
captured by variation at a single marker. Hence, there has been
increasing interest in using haplotypes, rather than single
markers, as the unit of analysis in association studies (92). A
haplotype refers to multiple SNPs along a short region of a
chromosome (e.g., within a gene) that occur in a block pattern
(Figure 4). There are three good reasons to perform haplotype
analysis as part of candidate gene association studies: a) a
haplotype might be in higher LD with the causal locus than
any of the individual markers, b) interactions among the
individual markers might form a functional haplotype, and c)
haplotype analysis reduces the number of multiple tests of
individual SNP analysis. A common problem of all statistical
methods that use haplotype information is linkage phase am-
biguity; i.e., it is unknown which alleles are located on the
maternal chromosome and which are located on the paternal
Figure 4. Three-SNP haplotypes and genotypes. The upper part of the
figure shows the eight haplotypes that can be formed from three SNPs that are
in full linkage equilibrium (the general rule is 2n with n  the number of
SNPs). These eight haplotypes give rise to the 36 different genotypes (the
general rule is ((m  1)*m)/2 with m the number of haplotypes). Because
genotyping does not discriminate between paternal or maternal alleles, the
upper part of the matrix (blue) has identical genotypes as the lower part of the
matrix. The genotypes printed boldface unambiguously translate to haplo-
types. All other genotypes printed in black can derive from multiple combi-
nations of haplotypes. If the SNPs are in linkage disequilibrium, only a few
of these possible haplotypes and genotypes will be observed in the population.
SNP  single nucleotide polymorphism.
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chromosome. As our genotyping analyses yield only the full
genotypes, not the parental alleles separately, we do not know
from which haplotype (maternal or paternal) the alleles origi-
nated. When multiple members in a family are genotyped, pref-
erably including the parents, the two haplotypes constituting each
genotype can often be determined from the Mendelian principles
of gene segregation within a pedigree. Alternatively, statistical
algorithms can be used to reconstruct haplotypes in unrelated
individuals using the frequency and correlation of the SNPs in
the population. The reliability of such algorithms seems to be
good for multiple diallelic markers, such as SNPs (93,94),
although there is some power loss for the association tests as
a result of the haplotype phase uncertainty.
Because the SNPs in a haplotype are strongly associated (in
LD) with each other, it is possible to test for the association of
a haplotype with a trait or disease by genotyping only a few
SNPs (“haplotype tagging” SNPs or simply “tagging” SNPs)
within the haplotype. Tagging SNPs are first selected in a
subset of the sample or in samples of the same ethnicity from
freely available web resources, such as the HapMap. This
reduces the cost of genotyping in the full sample, yet it ensures
reasonably good coverage of common variation throughout
the gene. The tagging SNPs are then examined for association
with the trait of interest in the total sample and the effects of
unassayed SNPs would then be detected through LD with
tagging SNPs (95). The International Hapmap project (avail-
able at http://www.hapmap.org) has characterized 4 million
SNP markers on a genome-wide scale in three ethnic groups
(Caucasians, Africans, and Asians), greatly facilitating the use
of tagging SNPs in association studies.
Power and Sample Size Considerations
Although many power calculations required for genetic
association studies may be derived from texts well known to
behavioral researchers (96,97), excellent on-line resources
specific to power and sample size calculations for genetic
association studies also exist, e.g., Quanto (98) available at
http://hydra.usc.edu/gxe and the Genetic Power Calculator
(99) available at http://statgen.iop.kcl.ac.uk/gpc/. In molecular
genetic studies of quantitative traits, assuming a simple addi-
tive model, the effect size of a locus is a function of mean trait
differences between homozygotes (e.g., the CC versus GG
genotype) and allele frequency (100). Differing modes of
inheritance (additive, dominant, and recessive) will also influ-
ence the effect size and have resulting effects on power and
sample size.
As psychosomatic traits are likely to be influenced by
multiple genes and interactions of small effect, the effect size
for each is generally expected to be small. Sample sizes
required to detect gene main effects and gene  environment
interaction with sufficient statistical power in this context are
relatively large. Although previous studies (98,99) have sug-
gested that association can be detected even in modestly sized
samples, standard power calculations show that up to 1000
participants are required to detect gene main effects and
approximately 1500 to 2000 participants are required to detect
gene  environment interaction with small to medium effect
sizes. The required sample size will be even larger if one of
the alleles is rare (e.g., less than 5% to 10%) or a large number
of markers is typed and the statistical criterion, typically set at
  0.05 for two-tailed tests, must be adjusted for multiple
comparisons. One method to adjust for multiple comparisons
is to use techniques that control the false discovery rate
(FDR), i.e., the proportion of significant findings (or discov-
eries) that are false-positives (101,102).
Integration
Although statistical analysis of genetic association may, in
many cases, be conducted using well-known methods, the
strength of the interpretation of results is grounded in the
study design. Nonsignificant results may be attributable to
Type II error (at 80% power, there remains a 20% chance that
you will falsely accept the null hypothesis) or experimental
biases like genotyping error or overmatching of controls (65).
Many prior studies have lacked sufficient statistical power (at
least 80%) to detect the small effects expected, particularly if
gene-gene, gene-environment, or genetic heterogeneity (i.e.,
more than one genetic variant can produce the same outcome)
effects are involved. In addition, negative results could be due
to inadequate coverage of a gene, for example, in studies of
single variants. Nonsignificant results may also be attributable
to a true lack of etiological relationship (65). Given the im-
portance of nonreplications in the literature, calls have been
made for convenient formats to publish negative results
(65,89,103).
A significant result may indicate that a causal relationship
between genotype and trait has been identified. However,
because there are several other potential explanations of sig-
nificant results, this type of interpretation should be used with
caution. A common cause of false-positive results is increased
Type I error due to multiple statistical tests. This problem will
only increase with the availability of high throughput meth-
ods, which can easily generate millions of genotypes. The
optimal correction method for multiple comparisons depends
on the number of markers and phenotypes studied. For exam-
ple, correction is mandatory for whole genome studies that use
large numbers of random markers but may not always be
necessary for candidate gene studies in which the prior prob-
ability of a true discovery is likely to be higher (104) and in
which gene-wide significance levels can be used (105). The
issue is further complicated by the correlation between SNPs
(LD) and between phenotypes, making it difficult to assess the
number of independent tests. Recently Manly and colleagues
(104) showed that correction techniques for multiple compar-
isons based on the original Bonferroni are generally too con-
servative. New procedures based on FDR effectively control
the proportion of false discoveries without sacrificing the
power to discover.
Population stratification is another source of false-positive
results. Although it is less likely that spurious association due
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to population stratification will occur among seemingly ho-
mogeneous populations, such as European Americans, this
type of bias remains a concern particularly among recently
admixed populations, such as African Americans and His-
panic Americans, and populations of mixed racial and ethnic
composition. It is also possible that the genetic marker show-
ing significant association is not the causal variant per se but
is co-inherited (in LD) with a causal variant. Many of these
threats to the interpretation of the results may be mitigated with
careful study design, such as appropriate correction for multiple
comparisons, incorporation of genetic markers to characterize
population substructure, and haplotyping to characterize variation
throughout a candidate gene. Most importantly, to minimize the
probability that an observed association is a false-positive, sig-
nificant findings must be replicated in independent samples.
Many of these issues may be novel for persons considering
genetic research for the first time and consultation on study
designs with geneticists, statistical geneticists, or genetic epide-
miologists is always recommended.
Finally, although this review focused on methods for can-
didate gene association studies, it should be noted that for
most complex traits, our knowledge of underlying causative
pathways is likely incomplete. Limiting the search for con-
tributing genetic variation to known candidate genes only will
likely prevent the identification of potentially novel pathways
that contribute to psychosomatic traits. Thus, the candidate
gene approach should ideally capitalize on knowledge gener-
ated with genome-wide searches, using techniques such as
linkage analysis (106) and genome-wide association (107).
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ERRATUM
While drafting a related article, the authors of an article published last year discovered an error in the description of how
sample size was calculated (Frasure-Smith N, Koszycki D, Swenson JR, Baker B, van Zyl LT, Laliberte´ M-A, Abramson
BL, Lambert J, Gravel G, Lespe´rance F. Design and rationale for a randomized, controlled trial of interpersonal
psychotherapy and citalopram for depression in coronary artery disease (CREATE). Psychosom Med 2006;68:87–93). On
page 91, in the second paragraph of the Sample Size section, points 5 and 6 should have read as follows: “5) adjustment
for loss of final assessment of not more than 5% (n/0.95); (6) adjustment for noncompletion of 12 weeks of treatment of
not more than 20% in each group (n/((1- 0.20)2).”
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